An Immunotherapy Fights Tumors by Recruiting the Messengers of the Immune System (1 of 1) (IMAGE)

American Association for the Advancement of Science (AAAS)

An Immunotherapy Fights Tumors by Recruiting the Messengers of the Immune System (1 of 1)

Caption

IL-2 immunotherapy expands tumor-infiltrating DCs through a lymphoid pathway, favoring the conversion of poorly immunogenic into immunogenic tumors. This material relates to a paper that appeared in the Sep. 16, 2020, issue of Science Translational Medicine, published by AAAS. The paper, by M.E. Raeber at University Hospital Zurich in Zurich, Switzerland; and colleagues was titled, "Interleukin-2 signals converge in a lymphoid-dendritic cell pathway that promotes anticancer immunity."

Credit

[Credit: <i>Raeber et al</i>.]

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.